Citation Impact
Citing Papers
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Top 10 Challenges in Cancer Immunotherapy
2020
Emerging evidence on the pathobiology of mucositis
2013
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Emerging evidence on the pathobiology of mucositis
2013
Immunopathology of multiple sclerosis
2015 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
2013 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Clinical multi-omics strategies for the effective cancer management
2017
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
2010
Antibody-Mediated Encephalitis
2018 Standout
Paraneoplastic neurological syndromes
2013
Autoimmune encephalopathies
2014
Anti-LGI1–associated cognitive impairment
2016
Therapeutic cancer vaccines
2015
Combining anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) and -programmed cell death protein 1 (PD-1) agents for cancer immunotherapy
2021
Works of Reyes Bernabé being referenced
What do we need to make circulating tumour DNA (ctDNA) a routine diagnostic test in lung cancer?
2017
Correlation between gender and spontaneous C-cell tumors in the thyroid gland of the Wistar rat
1999
Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis
2019
Determination of Neuronal Antibodies in Suspected and Definite Creutzfeldt-Jakob Disease
2013
Neoadjuvant chemo/immunotherapy for the treatment of stages IIIA resectable non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study—NADIM study-SLCG.
2018
Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer
2008
Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1.
2020